According to the Smith and Casadevall paper, which group of individuals is at increased risk of infection in disaster microbiology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immunocompromised Individuals Are at Increased Risk in Disaster Microbiology

According to disaster microbiology principles and the broader context of infection risk, those with compromised immune systems, such as individuals undergoing chemotherapy, face the greatest increased risk of infection during disasters.

Understanding the Risk Framework

The Smith and Casadevall paper on disaster microbiology 1 establishes that disasters create environmental changes that alter microbial populations and ecological interactions, with potentially adverse consequences for vulnerable populations. When we examine who is most susceptible to these disaster-related microbial threats, the evidence consistently points to immunocompromised individuals.

Why Immunocompromised Patients Are Most Vulnerable

Baseline Infection Susceptibility

Immunocompromised patients—particularly those undergoing chemotherapy—already face substantially elevated infection risks even under normal circumstances 2, 3. These patients include:

  • Neutropenic patients (absolute neutrophil count <500 cells/mcL) who have 10-20% risk of bloodstream infections 2, 4
  • Patients with hematologic malignancies experiencing hypogammaglobulinemia 2
  • Those receiving immunosuppressive therapy including chemotherapy, radiation, and anti-rejection medications 5
  • CAR T-cell therapy recipients with prolonged lymphopenia and hypogammaglobulinemia 3

Disaster-Amplified Risks

During disasters, these baseline vulnerabilities become catastrophically amplified through multiple mechanisms:

Infrastructure breakdown leads to:

  • Loss of adequate WASH (water, sanitation, hygiene) facilities 6
  • Disrupted access to specialized medical care and antimicrobial prophylaxis 7
  • Delayed surgical interventions and wound care 8
  • Supply chain interruptions for essential medications 7

Microbial environment changes result in:

  • Emergence of multidrug-resistant organisms (99% carbapenem resistance in Acinetobacter following earthquakes) 8
  • Predominance of gram-negative pathogens in disaster settings 8
  • New ecological niches favoring pathogenic microbes 1

Why Other Groups Are Not the Answer

  • Healthy individuals have intact immune defenses that can respond to disaster-related microbial challenges
  • Urban dwellers may actually have better access to emergency medical infrastructure during disasters
  • Vaccinated individuals maintain protective immunity against vaccine-preventable diseases regardless of disaster conditions

Clinical Implications

For immunocompromised patients in disaster settings, the risk cascade includes 9, 8:

  • 70-100% incidence of febrile episodes during neutropenia
  • 40% progression to severe sepsis or septic shock with intensive chemotherapy
  • Mortality rates significantly higher than immunocompetent disaster victims

The critical window for intervention is early: prolonged entrapment, tissue necrosis, and delayed surgical care independently predict wound infections in disaster victims 8, but these risks are exponentially higher in immunocompromised hosts who lack the neutrophil response needed to contain initial contamination 2, 9.

Common Pitfall to Avoid

Do not assume that disaster preparedness plans adequately address immunocompromised populations—most disaster response committees are unaware of diabetes and cancer-related needs 7. Proactive identification of vulnerable patients and pre-disaster planning for continued immunosuppressive therapy, antimicrobial prophylaxis, and infection surveillance is essential 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.